PCSA
Processa Pharmaceuticals Inc
NASDAQ: PCSA · HEALTHCARE · BIOTECHNOLOGY
$2.70
+1.89% today
Updated 2026-04-30
Market cap
$7.93M
P/E ratio
—
P/S ratio
1,320.06x
EPS (TTM)
$-10.36
Dividend yield
—
52W range
$2 – $20
Volume
0.1M
Processa Pharmaceuticals Inc (PCSA) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
4 of 8
Last 8 quarters
Avg EPS surprise
+42.5%
Last 4 quarters
Revenue YoY growth
—
Most recent quarter
EPS YoY growth
+93.2%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
-10.1%
Last 1 reports
Positive reaction rate
0%
0 of 1 quarters
Largest single-day move
-10.1%
2025-11-06
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2025-11-06 | $-0.07 | +84.4% | $0.34 | $0.31 | -10.1% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-09-30 | $-0.45 | $-0.07 | +84.4% | — | — |
| 2025-06-30 | $-0.23 | $-0.25 | -8.7% | — | — |
| 2025-03-31 | $-1.18 | $-0.30 | +74.6% | — | — |
| 2024-12-31 | $-0.92 | $-0.74 | +19.6% | $12.47M | — |
| 2024-09-30 | $-1.00 | $-1.03 | -3.0% | — | — |
| 2024-06-30 | $-0.98 | $-1.01 | -3.1% | — | — |
| 2024-03-31 | $-1.18 | $-1.11 | +5.9% | — | — |
| 2023-12-31 | $-1.60 | $-1.70 | -6.2% | — | — |
| 2023-09-30 | $-0.10 | $-0.08 | +20.0% | — | — |
| 2023-06-30 | $-0.23 | $-0.10 | +57.8% | — | — |
| 2023-03-31 | $-0.28 | $-0.18 | +35.7% | — | — |
| 2022-12-31 | $-0.32 | $-0.36 | -12.5% | — | — |
Frequently asked questions
Has Processa Pharmaceuticals Inc beaten earnings estimates?
Processa Pharmaceuticals Inc has beaten Wall Street EPS estimates in 4 of its last 8 quarterly reports, with an average EPS surprise of +42.5% over the last 4 quarters.
How does PCSA stock react to earnings?
PCSA stock has moved an average of -10.1% in the trading day following earnings over its last 1 reports, with positive reactions in 0% of those quarters.